IQVIA Holdings (FRA:QTS) Accounts Payable: €3,148 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:QTS IQVIA Holdings Inc FRA:QTS
88 GF Score
Price €180.15
GF Value €217.71
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings Accounts Payable?

IQVIA Holdings FRA:QTS -1.04% 88 Accounts Payable is €3,148 Mil as of Mar. 2026. GuruFocus rates FRA:QTS with a GF Score™ of 88/100 and a GF Value™ of €217.71 (Modestly Undervalued). The stock has 3 warning signs investors should review.

IQVIA Holdings's Accounts Payable for the quarter that ended in Mar. 2026 was €3,148 Mil.

IQVIA Holdings's quarterly Accounts Payable declined from Sep. 2025 (€3,025 Mil) to Dec. 2025 (€666 Mil) but then increased from Dec. 2025 (€666 Mil) to Mar. 2026 (€3,148 Mil).

IQVIA Holdings's annual Accounts Payable increased from Dec. 2023 (€650 Mil) to Dec. 2024 (€703 Mil) but then declined from Dec. 2024 (€703 Mil) to Dec. 2025 (€666 Mil).

IQVIA Holdings Accounts Payable Related Terms

IQVIA Holdings Accounts Payable Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings Accounts Payable Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 549.59 608.88 650.15 702.88 666.12

IQVIA Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,292.08 2,946.93 3,024.60 666.12 3,147.74
FRA:QTS
88GF Score
IQVIA Holdings Inc FRA:QTS
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €3,148 Mil mean?
IQVIA Holdings (FRA:QTS) has a Accounts Payable of €3,148 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on IQVIA Holdings and its competitors.
Is IQVIA Holdings' Accounts Payable too high?
IQVIA Holdings' current Accounts Payable is €3,148 Mil. Overall, IQVIA Holdings has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Accounts Payable compare to WAT and ILMN?
IQVIA Holdings' Accounts Payable of €3,148 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on IQVIA Holdings and its competitors. IQVIA Holdings's current Accounts Payable is €3,148 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (FRA:QTS) is currently considered Modestly Undervalued. The stock's GF Value™ is €217.71, compared to a current price of €180.15 — trading 17.3% below its estimated fair value. The current Accounts Payable is €3,148 Mil. IQVIA Holdings' overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For IQVIA Holdings (FRA:QTS), the current Accounts Payable is €3,148 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (FRA:QTS) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of €180.15 is trading 17.3% below its estimated GF Value™ of €217.71. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for FRA:QTS:

  • Accounts Payable: €3,148 Mil
  • GF Value™: €217.71 vs. price of €180.15 (17.3% below fair value)
  • GF Score™: 88/100 with 3 warning signs

No single metric tells the full story. See the FRA:QTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
88GF Score

Get the complete analysis for FRA:QTS

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€180.15
Price
€217.71
GF Value